Cytotrait Secures £3M to Revolutionize Agricultural Gene-Editing: A New Era for Crop Development
By Freecker • 2026-03-09T16:00:17.534016
In a significant boost to the field of agricultural gene-editing, Cytotrait, a University of Manchester spinout, has successfully raised £3 million in seed funding. This substantial investment, led by Northern Gritstone and supported by the UK Innovation & Science Seed Fund and the Northern Universities Ventures Fund, underscores the potential of Cytotrait's groundbreaking technology to transform the future of food production.
The core of Cytotrait's innovation lies in its proprietary MOSS (Mutant Organelle Selection System) platform, which enables the precise introduction of genes and gene edits into plant organelles such as chloroplasts and mitochondria. This approach allows for the rapid achievement of homoplasmy, a state where the desired genetic change is uniformly present across all organelles within a cell or plant, thereby overcoming a major hurdle in plant genetic engineering.
By facilitating the development of crops with enhanced traits, Cytotrait's technology holds the promise of improving crop yields, enhancing resistance to pests and diseases, and supporting the creation of hybrid crops. Furthermore, it could play a pivotal role in introducing new food-related traits and contributing to agricultural practices that enhance carbon capture, a critical aspect of global efforts to mitigate climate change.
The implications of Cytotrait's technology extend beyond the agricultural sector, with potential impacts on food security, sustainability, and the environment. For everyday consumers, this could mean access to a wider variety of nutritious and resilient food products. From an industry perspective, the technology could streamline regulatory pathways and support more efficient and sustainable agricultural practices.
As Cytotrait plans to utilize the funding to expand its research programs focusing on key crops such as wheat, maize, potato, and canola in European and North American markets, the company is poised to make significant strides in the application of its MOSS platform. This includes exploring improvements in crop yield and resilience, the development of new food traits, and approaches that may support more sustainable agricultural practices, including enhanced carbon sequestration.
The future of agriculture is on the cusp of a revolution, with gene-editing technologies like Cytotrait's MOSS platform at the forefront. As the world grapples with the challenges of food security and sustainability, innovations in this field are not only timely but crucial for ensuring a resilient and food-secure future for generations to come.
In conclusion, Cytotrait's £3 million funding round is a testament to the potential of its technology to address some of the most pressing challenges in agriculture. With its sights set on transforming the future of crop development, Cytotrait is leading the charge towards a more sustainable and secure food system.
The core of Cytotrait's innovation lies in its proprietary MOSS (Mutant Organelle Selection System) platform, which enables the precise introduction of genes and gene edits into plant organelles such as chloroplasts and mitochondria. This approach allows for the rapid achievement of homoplasmy, a state where the desired genetic change is uniformly present across all organelles within a cell or plant, thereby overcoming a major hurdle in plant genetic engineering.
By facilitating the development of crops with enhanced traits, Cytotrait's technology holds the promise of improving crop yields, enhancing resistance to pests and diseases, and supporting the creation of hybrid crops. Furthermore, it could play a pivotal role in introducing new food-related traits and contributing to agricultural practices that enhance carbon capture, a critical aspect of global efforts to mitigate climate change.
The implications of Cytotrait's technology extend beyond the agricultural sector, with potential impacts on food security, sustainability, and the environment. For everyday consumers, this could mean access to a wider variety of nutritious and resilient food products. From an industry perspective, the technology could streamline regulatory pathways and support more efficient and sustainable agricultural practices.
As Cytotrait plans to utilize the funding to expand its research programs focusing on key crops such as wheat, maize, potato, and canola in European and North American markets, the company is poised to make significant strides in the application of its MOSS platform. This includes exploring improvements in crop yield and resilience, the development of new food traits, and approaches that may support more sustainable agricultural practices, including enhanced carbon sequestration.
The future of agriculture is on the cusp of a revolution, with gene-editing technologies like Cytotrait's MOSS platform at the forefront. As the world grapples with the challenges of food security and sustainability, innovations in this field are not only timely but crucial for ensuring a resilient and food-secure future for generations to come.
In conclusion, Cytotrait's £3 million funding round is a testament to the potential of its technology to address some of the most pressing challenges in agriculture. With its sights set on transforming the future of crop development, Cytotrait is leading the charge towards a more sustainable and secure food system.